Effects of thai medicinal herb extracts with anti-psoriatic activity on the expression on NF-κb signaling biomarkers in hacat keratinocytes

Molecules

Volumn 16, Issue 5, 2011, Pages 3908-3932

  Saelee, Chanachai ^a   Thongrakard, Visa ^a   Tencomnao, Tewin ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Gene expression; Keratinocytes; NF kB signaling biomarkers; Psoriasis; Thai medicinal herbs

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT;

ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; HUMAN; KERATINOCYTE; MEDICINAL PLANT; METABOLISM; PSORIASIS;

CELL LINE; HUMANS; KERATINOCYTES; NF-KAPPA B; PLANT EXTRACTS; PLANTS, MEDICINAL; PSORIASIS;

EID: 79957600421     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16053908     Document Type: Article

References (37)

1. Lowes, M.A.; Bowcock, A.M.; Krueger, J.G. Pathogenesis and therapy of psoriasis. Nature 2007, 445, 866-873.
2. Schon, M.; Boehncke, W. Medical progress. Psoriasis. N. Engl. J. Med. 2005, 352, 1899-1912.
3. Ronpirin, C.; Tencomnao, T. Psoriasis: A review of the role of serotonergic system. Afr. J. Biotechnol. 2010, 9, 1528-1534.
4. Shenying, F.; Xiangzhong, F.; Momiao, X. Psoriasis prediction from genome-wide SNP profiles. BMC Dermatol. 2011, 11, 1.
5. Nair, R.P.; Duffin, K.C.; Helms, C.; Ding, J.; Stuart, P.E.; Goldgar, D.; Gudjonsson, J.E.; Li, Y.; Tejasvi, T.; Feng, B.J.; et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 2009, 41, 199-204.
6. Li, Q.; Verma, I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2, 725-734.
7. Qin, J.Z.; Chaturvedi, V.; Denning, M.F.; Choubey, D.; Diaz, M.O.; Nickoloff, B.J. Role of NF-κB in the apoptotic-resistant phenotype of keratinocytes. J. Biol. Chem. 1999, 274, 37957.
8. Tak, P.P.; Firestein, G.S. NF-kappaB: A key role in inflammatory diseases. J. Clini. Invest. 2001, 107, 7-12.
9. Takao, J.; Yudate, T.; Das, A.; Shikano, S.; Bonkobara, M.; Ariizumi, K.; Cruz, J. Expression of NF-κB in epidermis and the relationship between NF-κB activation and inhibition of keratinocyte growth. Br. J. Dermatol. 2003, 148, 680-688. (Pubitemid 36629745)
10. Lizzul, P.; Aphale, A.; Malaviya, R.; Sun, Y.; Masud, S.; Dombrovskiy, V.; Gottlieb, A. Differential Expression of Phosphorylated NF-kB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-kB in Response to Treatment with Etanercept. J. Invest. Dermatol. 2005, 124, 1275.
11. Johansen, C.; Flindt, E.; Kragballe, K.; Henningsen, J.; Westergaard, M.; Kristiansen, K.; Iversen, L. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. J. Invest. Dermatol. 2005, 124, 1284-1292. (Pubitemid 40847417)
12. Gerondakis, S.; Grossmann, M.; Nakamura, Y.; Pohl, T.; Grumont, R. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: Transgenics and knockouts. Oncogene 1999, 18, 6888-6895.
13. Saurat, J.H.; Stingl, G.; Dubertret, L.; Papp, K.; Langley, R.G.; Ortonne, J.P.; Unnebrink, K.; Kaul, M.; Camez, A. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br. J. Dermatol. 2008, 158, 558-566. (Pubitemid 351239154)
14. Burden, A.D. Health economics and the modern management of psoriasis. Br. J. Dermatol. 2010, 163, 670-671.
15. Gelfand, J.M.; Feldman, S.R.; Stern, R.S.; Thomas, J.; Rolstad, T.; Margolis, D.J. Determinants of quality of life in patients with psoriasis: A study from the US population. J. Am. Acad. Dermatol. 2004, 51, 704-708. (Pubitemid 39516879)
16. Thongrakard, V. Screening of Thai medicinal plant extracts for in vitro anti-psoriatic activity. Master's degree thesis, Chulalongkron University: Bangkok, Thailand, 2009.
17. Nickoloff, B.J.; Karabin, G.D.; Barker, J.N.; Griffiths, C.E.; Sarma, V.; Mitra, R.S.; Elder, J.T.; Kunkel, S.L.; Dixit, V.M. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am. J. Pathol. 1991, 138, 129-140.
18. Boukamp, P.; Petrussevska, R.T.; Breitkreutz, D.; Hornung, J.; Markham, A.; Fusenig, N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106, 761-771. (Pubitemid 18089976)
19. Tencomnao, T.; Ronpirin, C.; Prasansuklab, A.; Poovorawan, Y. Decreased EGFR mRNA expression in response to antipsoriatic drug dithranol in vitro. Afr. J. Biotechnol. 2009, 8, 3141-3146.
20. Tse, W.P.; Che, C.T.; Liu, K.; Lin, Z.X. Evaluation of the anti-proliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells. J. Ethnopharmacol. 2006, 108, 133-141. (Pubitemid 44498993)
21. Heyninck, K.; Beyaert, R. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 2005, 30, 1-4. (Pubitemid 40093732)
22. Beinke, S.; Ley, S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 2004, 382, 393-409. (Pubitemid 39243905)
23. Abdou, A.G.; Hanout, H.M. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. J. Cutan. Pathol. 2008, 35, 445-451. (Pubitemid 351519411)
24. Beljaards, R.C.; Van Beek, P.; Nieboer, C.; Stoof, T.J.; Boorsma, D.M. The expression of interleukin-8 receptor in untreated and treated psoriasis. Arch. Dermatol. Res. 1997, 289, 440-443. (Pubitemid 27371048)
25. Ohta, Y.; Hamada, Y. In situ Expression of CD40 and CD40 ligand in psoriasis. Dermatology 2004, 209, 21-28. (Pubitemid 39179101)
26. Cabrijan, L.; Lipozencic, J.; Batinac, T.; Lenkovic, M.; Stanic Zgombic, Z. Influence of PUVA and UVB radiation on expression of ICAM-1 and VCAM-1 molecules in psoriasis vulgaris. Coll. Antropol. 2008, 32, 53-56.
27. Boots, A.W.; Wilms, L.C.; Swennen, E.L.R.; Kleinjans, J.; Bast, A.; Haenen, G.R.M.M. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 2008, 24, 703-710. (Pubitemid 351783378)
28. Satoskar, R.R.; Shah, S.J.; Shenoy, S.G. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol. 1986, 24, 651-654. (Pubitemid 17205963)
29. Ohata, T.; Fukuda, K.; Murakami, A.; Ohigashi, H.; Sugimura, T.; Wakabayashi, K. Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells. Carcinogenesis 1998, 19, 1007.
30. Fisker, S.; Hansen, B.; Fuglsang, J.; Kristensen, K.; Ovesen, P.; Orskov, H.; Jorgensen, J.O. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: Relationship to GH-binding protein. Eur. J. Endocrinol. 2004, 150, 773-777. (Pubitemid 38961649)
31. Sun, Q.H.; Peng, J.P.; Xia, H.F.; Yang, Y. IFN-gamma promotes apoptosis of the uterus and placenta in pregnant rat and human cytotrophoblast cells. J. Interferon Cytokine Res. 2007, 27, 567-578. (Pubitemid 47122716)
32. Schaumann, D.H.; Tuischer, J.; Ebell, W.; Manz, R.A.; Lauster, R. VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF. Mol. Immunol. 2007, 44, 1606-1612.
33. Braam, B.; de Roos, R.; Dijk, A.; Boer, P.; Post, J.A.; Kemmeren, P.P.; Holstege, F.C.; Bluysen, H.A.; Koomans, H.A. Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells. Am. J. Physiol. Heart. Circ. Physiol. 2004, 287, H1977-H1986. (Pubitemid 39430733)
34. Zhang, D.; Li, Y.; Bi, Z.; Wang, C.; Ouyang, J.; Wang, B.; Bi, Y. Sodium ferulate modified gene expression profile of oxidized low-density lipoproteins-treated endothelial cells. FASEB J. 2009, 14, 302-313.
35. Gill, K.; Kirma, N.; Gunna, V.S.; Santanam, N.; Parthasarathy, S.; Tekmal, R.R. Regulation ofcolony stimulating factor-1 (CSF-1) in endometrial cells: Glucocorticoids and oxidative stressregulate the expression of CSF-1 and its receptor c-fms in endometrial cells. Fertil. Steril. 2001,76, 1005-1011. (Pubitemid 33031329)
36. Basok, A.; Shnaider, A.; Man, L.; Chaimovitz, C.; Douvdevani, A. CD40 is expressed on humanperitoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J. Am.Soc. Nephrol. 2001, 12, 695.
37. Vogel, C.F.; Sciullo, E.; Li, W.; Wong, P.; Lazennec, G.; Matsumura, F. RelB, a new partner ofaryl hydrocarbon receptor-mediated transcription. Mol. Endocrinol. 2007, 21, 2941-2955. (Pubitemid 350223506)